about
The Anti-Doping Movement.Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.Detection of human insulin-like growth factor-1 in deer antler velvet supplements.Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses.Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.Detection of autologous blood transfusions using a novel dried blood spot method.Mass Spectrometry Method to Measure Membrane Proteins in Dried Blood Spots for the Detection of Blood Doping Practices in Sport.Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H.lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.Metabolism of methylstenbolone studied with human liver microsomes and the uPA⁺/⁺-SCID chimeric mouse model.Iatrogenic Cushing Syndrome in a Child With Congenital Adrenal Hyperplasia: Erroneous Compounding of Hydrocortisone.Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.A population study of urine glycerol concentrations in elite athletes competing in North America.Detection of LGD-4033 and its metabolites in athlete urine samples.HPT-Axis Effects and Urinary Detection Following Clomiphene Administration in MalesIntravenous Iron Does Not Augment the Hemoglobin Mass Response to Simulated HypoxiaEvaluation of serum markers for improved detection of autologous blood transfusionsDetection and in vitro metabolism of AOD9604Sensitive quantification of IGF-1 and its synthetic analogs in dried blood spotsDetection of GHRP-2 and GHRP-6 in urine samples from athletesInter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry
P50
Q38772774-59AF4024-B7DC-46BD-99EE-8C8479E08E3FQ39313399-86C5AC82-1A7C-4735-80CF-EB3CAB9D5428Q43665632-0378A0CC-4E55-42C7-AE5C-FBF41D1289AAQ43897602-47533F4D-C34C-4098-8F3D-897821055415Q47218016-F79F4047-C260-487B-BBCA-E7413A4060A9Q47306140-7D41D72B-ACF2-4EA6-BB68-849478C9B4BAQ47633984-22DF3E86-2EE2-4BF0-9D51-CA6E0124D9ACQ47921806-425465F8-3766-4354-97BB-AEDCDCC9F01BQ48106817-A66AFFF9-2B13-46BB-A9BC-A20730EAF996Q48319000-26C2329B-91C7-49E0-BF80-45E9C0C19E84Q49090499-D8D7945D-FA9B-4BDB-9E3D-5863041D3794Q50065199-49E9483C-22D9-4649-9800-DF58965BCECDQ50222097-D932FB8A-1BB5-4E7E-BCA8-96AF4C1622A4Q51175057-0BA1E071-FA92-4EEF-B577-66CA4E1F3576Q53734473-7F66C516-1A7E-4A28-BD4E-9D5B2E077075Q57184972-7C5718DF-4903-4772-A19A-6C6E6A4CDC09Q57765438-8C34852B-D022-4F52-9CF6-F56F87D79FCCQ58793848-B3EC4952-883E-4EE7-93D1-60E5AC19417FQ85288997-C6BB757A-17CE-4034-9FD5-06327279C7A7Q86027123-23F0D56E-7BAC-42A2-81D1-C2FF13CABA3FQ86992648-0007B657-4DBA-41FB-ABCE-6B284A4574D0Q90784619-1D5DF8F9-213A-47E6-BD65-8583E4583618
P50
name
Daniel Eichner
@en
Daniel Eichner
@nl
type
label
Daniel Eichner
@en
Daniel Eichner
@nl
prefLabel
Daniel Eichner
@en
Daniel Eichner
@nl